First-line (1-L) bevacizumab plus chemotherapy (Bev/CT) in...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

First-line (1-L) bevacizumab plus chemotherapy (Bev/CT) in colorectal cancer (CRC) patients with potentially resectable liver only (LM) or liver and lung metastases (LLM): KRAS mutation analysis of the non-interventional PICASSO study

Malka, D., Metges, J-P., Elias, D., Bennouna, J., Bonnetain, F., Dourthe, L-M., Ben Abdelghani, M., Radji, A., Laplaige, P., Laurent, F. Petit, Telliez, J., Bakiri, S., Rivoire, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw370.35
Date:
October, 2016
File:
PDF, 38 KB
english, 2016
Conversion to is in progress
Conversion to is failed